Economic and humanistic burden of illness in generalized anxiety disorder: an analysis of patient survey data in Europe
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Whilst studies suggest that generalized anxiety disorder (GAD) represents a considerable health care burden in Europe, there is a paucity of published evidence. This study investigated the burden of illness associated with GAD across five European countries (France, Germany, Italy, Spain, and the UK). METHODS: Information from the 2008 European National Health and Wellness Survey database was analyzed. Bivariate, multivariate, and cost analyses were used to compare patients with GAD and propensity-matched controls. RESULTS: Compared with non-GAD controls, patients with GAD had more comorbidities and were more likely to smoke but less likely to be employed, use alcohol, or take exercise. They also had significantly worse health-related quality of life, and significantly greater work impairment and resource use, which increased as GAD severity increased. Within-country analyses demonstrated results similar to those for the five European countries overall, with the largest differences in resource use between patients with GAD and non-GAD controls documented in France and Germany. The average mean differences in direct costs were relatively small between the GAD groups and controls; however, indirect costs differed substantially. Costs were particularly high in Germany, mainly due to higher salaries leading to higher costs associated with absence from work. The limitation of this study was that the data were from a self-reported Internet survey, making them subject to reporting bias and possibly sample bias. CONCLUSION: Across all five European countries, GAD had a significant impact on work impairment, resource use, and economic costs, representing a considerable individual and financial burden that increased with severity of disease. These data may help us to understand better the burden and costs associated with GAD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Validity and Reproducibility of a Work Productivity and Activity Impairment Instrument
Reilly, M. C., Zbrozek, A. S., & Dukes, E. M. (1993) · PharmacoEconomics · doi:10.2165/00019053-199304050-00006 · Cited by 3,071
The economic burden of anxiety disorders in the 1990s
Greenberg, P. E., Sisitsky, T., Kessler, R. C., Finkelstein, S. N., Berndt, E. R., Davidson, J. R. T., Ballenger, J. C., & Fyer, A. J. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0702 · Cited by 1,242
DSM-III-R Generalized Anxiety Disorder in the National Comorbidity Survey
Wittchen, H.-U. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950050015002 · Cited by 967
Quality of Life in Individuals With Anxiety Disorders
Mendlowicz, M. V., & Stein, M. B. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.5.669 · Cited by 955
Generalized anxiety disorder: prevalence, burden, and cost to society
Wittchen, H.-U. (2002) · Depression and Anxiety · doi:10.1002/da.10065 · Cited by 733
Human and economic burden of generalized anxiety disorder
Hoffman, D. L., Dukes, E. M., & Wittchen, H.-U. (2008) · Depression and Anxiety · doi:10.1002/da.20257 · Cited by 438
Cost of anxiety disorders in Europe
Andlin‐Sobocki, P., & Wittchen, H. ‐. (2005) · European Journal of Neurology · doi:10.1111/j.1468-1331.2005.01196.x · Cited by 165
Simon, N. M. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.s.7002.02 · Cited by 118
Newman, M. G., Przeworski, A., Fisher, A. J., & Borkovec, T. D. (2010) · Behavior Therapy · doi:10.1016/j.beth.2008.12.005 · Cited by 112
Munk-Jørgensen, P., Allgulander, C., Dahl, A. A., Foldager, L., Holm, M., Rasmussen, I., Virta, A., Huuhtanen, M.-T., & Wittchen, H.-U. (2006) · Psychiatric Services · doi:10.1176/ps.2006.57.12.1738 · Cited by 96
Bereza, B. G., Machado, M., & Einarson, T. R. (2009) · Clinical Therapeutics · doi:10.1016/j.clinthera.2009.06.004 · Cited by 89
Moffitt, T. E., Harrington, H., Caspi, A., Kim-Cohen, J., Goldberg, D., Gregory, A. M., & Poulton, R. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.6.651 · Cited by 41
Comprehensive review of generalized anxiety disorder in primary care in Europe.
Parmentier, H., García-Campayo, J., & Prieto, R. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2013.770731 · Cited by 37
Cited by
Economic Burden of Anxiety Disorders: A Systematic Review and Meta-Analysis
Konnopka, A., & König, H. (2020) · PharmacoEconomics · doi:10.1007/s40273-019-00849-7 · Cited by 259
Generalized anxiety disorder in urban China: Prevalence, awareness, and disease burden
Yu, W., Singh, S. S., Calhoun, S., Zhang, H., Zhao, X., & Yang, F. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.02.012 · Cited by 119
Ruiz-Rodríguez, P., Cano-Vindel, A., Muñoz Navarro, R., Medrano, L., Moriana, J. A., Buiza Aguado, C., Jiménez Cabré, G., & González-Blanch, C. (2017) · Ansiedad y Estrés · doi:10.1016/j.anyes.2017.10.003 · Cited by 50
Hirsch, C. R., Beale, S., Grey, N., & Liness, S. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00796 · Cited by 43
Xie, Z.-J., Han, N., Law, S., Li, Z.-W., Chen, S.-Y., Xiao, J.-P., Zhang, Y., Gao, B.-L., Jiang, S.-S., Gao, H.-M., et al. (2019) · Acta Neuropsychiatrica · doi:10.1017/neu.2019.32 · Cited by 10
Metadata
- Authors
- DiBonaventura, M., Toghanian, S., Järbrink, K., & Locklear, J.
- Venue
- ClinicoEconomics and Outcomes Research
- Publisher
- Informa UK Limited
- Published
- 2014-04
- Volume
- 6
- Pages
- 151
- ISSN
- 1178-6981 (ISSN-L)
- OpenAlex
- W2077040458
- Cited by
- 28
- References
- 13
- FWCI
- 1.91
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.